Discontinuation report MYLAN-SERTRALINE
Report ID | 30397 |
Drug Identification Number | 02242519 |
Brand name | MYLAN-SERTRALINE |
Common or Proper name | SERTRALINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-08-01 |
Actual discontinuation date | 2018-02-01 |
Remaining supply date | 2018-08-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Last lot 3047219 Expires 31-Oct-18. Resolved/Discontinued in ID 30402 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-23 | English | Compare |
v2 | 2017-11-23 | French | Compare |
v3 | 2018-02-02 | English | Compare |
v4 | 2018-02-02 | French | Compare |
v5 | 2018-02-15 | English | Compare |
v6 | 2018-02-15 | French | Compare |
Showing 1 to 6 of 6